Stop Meth Labs and Enhance Patient Access Act of 2015

Summary

Stop Meth Labs and Enhance Patient Access Act of 2015 This bill amends the Controlled Substances Act to revise the standard used by the Drug Enforcement Administration (DEA) to determine whether to exempt a scheduled listed chemical product from certain applicable requirements. (A scheduled listed chemical product is a nonprescription drug product that contains ephedrine, pseudoephedrine, or phenylpropanolamine.) Currently, the DEA may exempt retail sales of a scheduled listed chemical product from certain requirements (e.g., daily sales limits) if the product cannot be used to illegally manufacture methamphetamine. This bill allows the DEA to exempt retail sales of a scheduled listed chemical product from such requirements if it is not practical by processes known to be employed by clandestine laboratory operators to use the product to illegally manufacture methamphetamine.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 5 November 2015

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 5 November 2015

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 5 November 2015

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.